Core One Labs Inc C.COOL

Alternate Symbol(s): CLABF

Healthcare Cannabis

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.

CSE:COOL - Post by User

Core One Labs Inc

Bullboard Posts

Comment by SS76on Jan 31, 2019 11:29am

76 Views

Post# 29301399

RE:Over a 10 bagger if you compare to CVSI

DirkdiggIer wrote: LDS will absolute have revenue 1/2 their this month at least. That should valuation LDS @ $2.50. LDS will be close or matching their revenue in 3 or 4 months. That puts LDS @ 5.00 / share where they are now. Yup, LDS is insanely unrealisticly undervalued. $$$

Not really, but they are on their way. CVSI did $13M in q3.....LDS in q4 will likely report $3-$4M but keep in mind they will achieve those revenues while being handcuffed due to the ever changing regulations. I agree, they will be there soon enough, and under $1 will be a pipedream. This is going to be a $5 - $7 stock by the end of the year.

Bullboard Posts

Investors eye Australian gold mining projects amid promising developments